Characterization of discontinuation and nonpublication of phase III randomized clinical trials of psoriasis

被引：0
|
作者：
Lam, Megan [1 ]
Monaghan, Caitlin [2 ]
Chan, An-Wen [3 ,4 ]
Drucker, Aaron M. [3 ,4 ]
机构：
[1] McMaster Univ, Michael G DeGroote Sch Med, Fac Med, Hamilton, ON, Canada
[2] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[3] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada
[4] Univ Toronto, Div Dermatol, Toronto, ON, Canada
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 01期
关键词：
D O I：
10.1111/bjd.21025
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：127 / 129
页数：3
相关论文
共 50 条
  • [41] Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?
    Udayakumar, Suji
    Thomson, Sasha
    Razak, Albiruni R. Abdul
    Chan, Kelvin K. W.
    [J]. TARGETED ONCOLOGY, 2022, 17 (06) : 665 - 674
  • [42] Interphase clinical trials: Phase III/Phase IV
    O'Quigley, J
    Xu, RH
    Blin, P
    Charpak, Y
    [J]. BIOMETRICAL JOURNAL, 1999, 41 (07) : 773 - 782
  • [43] Randomized discontinuation trials with binary outcomes
    Fedorov V.V.
    Liu T.
    [J]. Journal of Statistical Theory and Practice, 2014, 8 (1) : 30 - 45
  • [44] RANDOMIZED DISCONTINUATION TRIALS - UTILITY AND EFFICIENCY
    KOPEC, JA
    ABRAHAMOWICZ, M
    ESDAILE, JM
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (09) : 959 - 971
  • [45] Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: Results from three randomized placebo-controlled phase III trials: Part I
    Pariser, David M.
    Gordon, Kenneth B.
    Papp, Kim A.
    Leonardi, Craig L.
    Kwon, Paul
    Compton, Peter G.
    Rundle, Amy Chen
    Walicke, Patricia A.
    Lebwohl, Mark
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2005, 9 (06) : 303 - 312
  • [46] Design Issues in Randomized Phase II/III Trials
    Korn, Edward L.
    Freidlin, Boris
    Abrams, Jeffrey S.
    Halabi, Susan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) : 667 - 671
  • [47] Current randomized phase III trials in gynecologic cancer
    不详
    [J]. ONCOLOGY-NEW YORK, 2004, 18 (13): : 1642 - +
  • [48] On the choice of doses for phase III clinical trials
    Lisovskaja, Vera
    Burman, Carl-Fredrik
    [J]. STATISTICS IN MEDICINE, 2013, 32 (10) : 1661 - 1676
  • [49] New antithrombotic agents in the treatment of VTE; a subgroup analysis of the Phase III randomized clinical trials
    Gerotziafas, G. T.
    Samama, M. M.
    Elalamy, I.
    [J]. THROMBOSIS RESEARCH, 2012, 129 : S160 - S160
  • [50] What's new in stroke? Phase III randomized clinical trials of 2012-2014
    Hart, Robert G.
    Ng, Kuan H.
    Perera, Kanjana S.
    Shoamanesh, Ashkan
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (06) : 790 - 795
12345